# FDA 483 - Joseph Thaddeus Beck, MD - October 02, 2020

Source: https://www.keypedia.com/records/483/joseph-thaddeus-beck-md/f35dd777-3514-48f7-9d49-01370f189b34

> FDA 483 for Joseph Thaddeus Beck, MD on October 02, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Joseph Thaddeus Beck, MD
- Inspection Date: 2020-10-02
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Joseph Thaddeus Beck, MD, a clinical investigator in Springdale, AR, revealed significant deviations from investigational plans and inadequate record-keeping. The inspection found failures in adverse event reporting, subject reconsenting, and adherence to assessment schedules, alongside deficiencies in investigational drug disposition records. These findings indicate a moderate level of non-compliance with clinical trial regulations.

## Related Officers

- [investigator](https://www.keypedia.com/people/corrine-m-carter/69e1be8c-1cd9-48d9-a08e-bf49060b94d6)

Company: https://www.keypedia.com/companies/joseph-thaddeus-beck-md/010f9e91-57dd-47f7-92f1-17d7f9927198

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9